Current opinion on use of luteinizing hormone supplementation in assisted reproduction therapy: An Asian perspective

Reproductive BioMedicine Online

Volumn 23, Issue 1, 2011, Pages 81-90

  Wong, Peng Cheang ^a   Qiao, Jie ^b   Ho, Clement ^c   Ramaraju, Gottumukkala A ^d   Wiweko, Budi ^e   Takehara, Yuji ^f   Nadkarni, Prashant V ^g   Cheng, Li Chang ^h   Chen, Hsin Fu ⁱ   Suwajanakorn, Somchai ^j   Vuong, Thi Ngoc Lan ^k  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

^c Assisted Reproductive Technology (ART) Laboratory   (Hong Kong)

^d Krishna IVF Clinic   (India)

^e CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

^f Advanced Medical Research Institute of Fertility   (Japan)

^g KL Fertility and Gynaecology Centre   (Malaysia)

^h Thomson Medical Centre   (Singapore)

ⁱ NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^j CHULALONGKORN UNIVERSITY   (Thailand)

^k UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY   (Viet Nam)

more..

Author keywords

Asia; GnRH agonist; IVF; ovarian stimulation; recombinant LH

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GANIRELIX; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; MUELLERIAN INHIBITING FACTOR; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

ASIAN; CONSENSUS DEVELOPMENT; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLICULAR PHASE; FOLLITROPIN RELEASE; HORMONAL REGULATION; HORMONAL THERAPY; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; INFERTILITY THERAPY; INTERNALIZATION; INTRACYTOPLASMIC SPERM INJECTION; LUTEINIZING HORMONE RELEASE; NONHUMAN; OOCYTE MATURATION; OVARY CYCLE; OVULATION; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; STEROIDOGENESIS; TREATMENT RESPONSE;

ADULT; AGE FACTORS; CHORIONIC GONADOTROPIN; FEMALE; FOLLICLE STIMULATING HORMONE; HALF-LIFE; HUMANS; LUTEINIZING HORMONE; OVARIAN FOLLICLE; OVULATION INDUCTION; PREGNANCY; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 79960364059     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2011.03.023     Document Type: Review

References (50)

1. B. Acevedo, M. Sanchez, J.L. Gomez, J. Cuadros, E. Ricciarelli, and E.R. Hernández Luteinizing hormone supplementation increases pregnancy rates in gonadotropin-releasing hormone antagonist donor cycles Fertil. Steril. 82 2004 343 347 (Pubitemid 39092033)
2. C. Alviggi, R. Clarizia, A. Mollo, A. Ranieri, and G. De Placido Outlook: who needs LH in ovarian stimulation? Reprod. Biomed. Online 12 2006 599 607 (Pubitemid 43674932)
3. C. Alviggi, R. Clarizia, K. Pettersson, A. Mollo, P. Humaidan, I. Strina, M. Coppola, A. Ranieri, M. D'Uva, and G. De Placido Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism Reprod. Biomed. Online 18 2009 9 14
4. G. Baer, and E. Loumaye Comparison of recombinant human luteinising hormone (r-hLH) and human menopausal gonadotropin (hMG) in assisted reproductive technology Curr. Med. Res. Opin. 19 2003 83 88 (Pubitemid 36548121)
5. J. Balasch, and F. Fábreques Is luteinizing hormone needed for optimal ovulation induction? Curr. Opin. Obstet. Gynecol. 14 2002 265 274 (Pubitemid 34557089)
6. G. Barrenetxea, J.A. Agirregoika, M.R. Jimenez, A. Lopez de Larruzea, T. Ganzabal, and K. Carbonero Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles Fertil. Steril. 8 2008 546 553 (Pubitemid 351335051)
7. M.J. Berger, and M.L. Taymor The role of luteinizing hormone in human follicular maturation and function Am. J. Obstet. Gynecol. 111 1971 708 710
8. E. Bosch Recombinant human FSH and recombinant human LH in a 2:1 ratio combination: a new tool for ovulation induction Expert Rev. Obstet. Gynecol. 4 2009 491 498
9. E. Bosch, E. Labarta, J. Crespo, C. Simón, J. Remohí, and A. Pellicer Impact of luteinizing hormone administration on gonadotropin- releasing hormone antagonist cycles: an age-adjusted analysis Fertil. Steril. 95 2011 1031 1036
10. B. Couzinet, N. Lestrat, S. Brailly, M. Forest, and G. Schaison Stimulation of ovarian follicular maturation with pure follicle stimulating hormone in women with gonadotropin deficiency J. Clin. Endocrinol. Metab. 66 1988 552 556 (Pubitemid 18076002)
11. G. De Placido, C. Alviggi, A. Mollo, I. Strina, A. Ranieri, E. Alviggi, M. Wilding, M.T. Varricchio, A.L. Borrelli, and S. Conforti Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation Clin. Endocrinol. 60 2004 637 643 (Pubitemid 38669856)
12. G. De Placido, C. Alviggi, A. Perino, I. Strina, F. Lisi, A. Fasolino, R. De Palo, A. Ranieri, N. Colacurci, A. Mollo Italian Collaborative Group on Recombinant Human Luteinizing Hormone Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial Hum. Reprod. 20 2005 390 396 (Pubitemid 40277606)
13. G. De Placido, A. Mollo, R. Clarizia, I. Strina, S. Conforti, and C. Alviggi Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response Fertil. Steril. 85 2006 247 250 (Pubitemid 43063461)
14. P. Devroey, B. Mannaerts, J. Smitz, H. Coelingh Bennink, and A. Van Steirteghem Clinical outcome of a pilot efficacy study on recombinant human follicle-stimulating hormone (Org 32489) combined with various gonadotropin-releasing hormone agonist regimens Hum. Reprod. 9 1994 1064 1069 (Pubitemid 24203895)
15. European Recombinant Human LH Study Group Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH-and FSH-deficient anovulatory women: a dose finding study J. Clin. Endocrinol. Metab. 83 1998 1507 1514
16. Falck, S., 1959. Site of the production of estrogen in rat ovary as studies in micro-transplants. Ph.D. Thesis, University of Lund, Sweden.
17. A.P. Ferraretti, L. Gianaroli, M.C. Magli, A. D'angelo, V. Farfalli, and N. Montanaro Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques Fertil. Steril. 82 2004 1521 1526 (Pubitemid 39611376)
18. M. Filicori, A.E. Cognini, C. Tabarelli, P. Pocognoli, S. Taraborrelli, D. Spettoli, and W. Ciampaglia Stimulation and growth of antral ovarian follicles by selective LH activity administration in women J. Clin. Endocrinol. Metab. 87 2002 1156 1161 (Pubitemid 36121081)
19. J.G. Franco Jr., R.L. Baruffi, and J.B. Oliveira Effects of recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-agonist protocol: a matched case-control study Reprod. Biol. Endocrinol. 7 58 2009 1 8
20. M.L. Grøndahl, R. Borup, Y.B. Lee, V. Myrhøj, H. Meinertz, and S. Sørensen Differences in gene expression of granulosa cells from women undergoing controlled ovarian hyperstimulation with either recombinant follicle-stimulating hormone or highly purified human menopausal gonadotropin Fertil. Steril. 91 2009 1820 1830
21. S.G. Hillier Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis Hum. Reprod. 9 1994 188 191 (Pubitemid 24076735)
22. S.G. Hillier The science of ovarian ageing - how might knowledge be translated into practice? S. Bewley, W. Ledger, D. Nikolaou, Reproductive Ageing 2009 RCOG Press London 75 87
23. S.G. Hillier Paracrine support of ovarian stimulation Mol. Hum. Reprod. 15 2009 843 850
24. J.N. Hugues, J. Soussis, I. Calderon, J. Balasch, R.A. Anderson, A. Romeu on behalf of the Recombinant LH Study Group Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study Hum. Reprod. 20 2005 629 635 (Pubitemid 40425487)
25. P. Humaidan, L. Bungum, M. Bungam, and C. Andersen Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation Hum. Reprod. 17 2002 2016 2021
26. P. Humaidan, M. Bungum, L. Bungam, and C. Yding Andersen Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study Reprod. Biomed. Online 8 2004 635 643 (Pubitemid 38744939)
27. C. Kailasam, S.D. Keay, P. Wilson, W.C. Ford, and J.M. Jenkins Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome Hum. Reprod. 19 2004 1544 1547 (Pubitemid 38997178)
28. E.M. Kolibianakis, L. Kalogeropoulou, G. Griesinger, E.G. Papanikolaou, J. Papadimas, J. Bontis, and B.C. Tarlatzis Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis Hum. Reprod. Update 13 2007 445 452 (Pubitemid 47299851)
29. R. Lahoud, M. Al-Jefout, J. Tyler, J. Ryan, and G. Driscoll A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates Hum. Reprod. 21 2006 2645 2649 (Pubitemid 44542158)
30. E. Loumaye, P. Engrand, Z. Shoham, S.G. Hillier, and D.T. Baird Clinical evidence for an LH 'ceiling' effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation Hum. Reprod. 18 2003 314 322 (Pubitemid 36236264)
31. F. Lisi, L. Rinaldi, S. Fishel, R. Lisi, G. Pepe, and M.G. Picconeri Use of recombinant follicle-stimulating hormone (Gonal F) and recombinant luteinizing hormone (Luveris) for multiple follicular stimulation in patients with a suboptimal response to in vitro fertilization Fertil. Steril. 79 2003 1037 1038 (Pubitemid 36385035)
32. J.Y. le Cotonnec, E. Loumaye, H.C. Porchet, V. Beltrami, and A. Munafo Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone Fertil. Steril. 69 1998 201 209 (Pubitemid 28117094)
33. D. Loutradis, E. Vomvolaki, and P. Drakakis Poor responder protocols for in-vitro fertilization: options and results Curr. Opin. Obstet. Gynecol. 20 2008 374 378
34. B. Mannaerts, R. de Leeuw, J. Geelen, A. Van Ravestein, P. Van Wezenbeek, A. Schuurs, and H. Kloosterboer Comparative in vitro and in vivo studies on the biological characteristics of recombinant human follicle stimulating hormone Endocrinology 129 1991 2623 2630
35. R. Marrs, D. Meldrum, S. Muasher, W. Schoolcraft, L. Werlin, and E. Kelly Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment Reprod. Biomed. Online 8 2004 175 182 (Pubitemid 38208463)
36. R. Matorras, B. Prieto, A. Exposito, R. Mendoza, L. Crisol, P. Herranz, and S. Burgués Mid-follicular LH supplementation in women aged 35-39 years undergoing ICSI cycles: a randomized controlled study Reprod. Biomed. Online 19 2009 879 987
37. E.A. McGee, and A.J. Hsueh Initial and cyclic recruitment of ovarian follicles Endocr. Rev. 21 2000 200 214 (Pubitemid 32275595)
38. K.M.J. Menon, A.K. Nair, and L. Wang A novel post-transcriptional mechanism of regulation of luteinizing hormone receptor expression by an RNA binding protein from the ovary Mol. Cell. Endocrinol. 246 2006 135 141 (Pubitemid 43238407)
39. M.H. Mochtar, F. van der Veen, M. Ziech, M. van Wely, and A. Musters Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles Cochrane Database Syst. Rev. 1 2009 1 38
40. K. Nakagawa, S. Ohgi, A. Nakashima, T. Horikawa, R. Sugiyama, and H. Saito The ratio of late-follicular to mid-follicular phase LH concentrations efficiently predicts ART outcomes in women undergoing ART treatment with GnRH-agonist long protocol and stimulation with recombinant FSH J. Assist. Reprod. Genet. 25 2008 359 364
41. L. O'Dea, F. O'Brien, K. Currie, and G. Hemsey Follicular development induced by recombinant luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in anovulatory women with LH and FSH deficiency: evidence of a threshold effect Curr. Med. Res. Opin. 24 2008 2785 2793
42. A. Pezzuto, B. Ferrari, F. Coppola, and G.B. Nardelli LH supplementation in down-regulated women undergoing assisted reproduction with baseline low serum LH levels Gynecol. Endocrinol. 26 2010 118 124
43. Z. Shoham The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation Fertil. Steril. 77 2002 1170 1177 (Pubitemid 34626325)
44. Z. Shoham, B. Mannaerts, V. Insler, and H. Coelingh-Bennink Induction of follicular growth using recombinant human follicle-stimulating hormone in two volunteer women with hypogonadotropic hypogonadism Fertil. Steril. 59 1993 738 742 (Pubitemid 23104171)
45. Thornton, K., Alper, M.M., Ezcurra, D., 2008. Outcomes of 1637 GnRH antagonist IVF cycles using LH supplementation for COH: rhFSH/rhLH vs. rhFSH/hMG. Fertil. Steril. 90 (Suppl.) S235.
46. Vuong, T.N.L., Ho, M.T., Pham, V.T., Nguyen, T.N.P., 2004. The addition of recombinant LH in poor-responder IVF patients. Presented at 18th World Congress on Fertility and Sterility, May 23-28, 2004, Montreal, Quebec, Canada (Abstract 307.6).
47. B.H. van de Weijer, J.W. Mulders, E.S. Bos, P.D. Verhaert, and H.W. van den Hooven Compositional analyses of a human menopausal gonadotrophin preparation extracted from urine (menotropin). Identification of some of its major impurities Reprod. Biomed. Online 7 2003 547 557 (Pubitemid 37455976)
48. S. Weil, K. Vendola, J. Zhou, and C.A. Bondy Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development J. Clin. Endocrinol. Metab. 84 1999 2951 2956 (Pubitemid 30642034)
49. L.G. Westergaard, S.B. Laursen, and C.Y. Andersen Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction Hum. Reprod. 15 2000 1003 1008 (Pubitemid 30251290)
50. Wiweko, B., 2010. Serum AMH level positively correlated with number of oocytes retrieved and negatively correlated with age and total gonadotropin. 3rd Congress of Asia Pacific Initiative on Reproduction. Oral presentation.